Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ESMO Congress 2026 · Barcelona, Spain
5 shown of 2,562 total abstracts
  1. Abstract 100372026-09-01 · 13:30 CT · E450
    Opdivo plus chemotherapy in previously untreated metastatic melanoma: updated analysis from CheckMate-692
    J. Brahmer, S. Peters, T. Mok, et al. · Royal Marsden Hospital
    Education SessionMelanoma📄🖼️
  2. Abstract 99952026-09-05 · 15:30 CT · S406
    CheckMate-235: Opdivo (nivolumab) 2L in metastatic melanoma
    A. Spira, J. Cortes, R. Herbst, et al. · Massachusetts General Hospital
    Education SessionMelanoma📄🖼️
  3. Abstract 104142026-09-03 · 15:15 CT · E450
    Opdivo plus chemotherapy in previously untreated metastatic melanoma: updated analysis from CheckMate-815
    A. Spira, M. Krop · Institut Gustave Roussy
    Education SessionMelanoma📄🖼️
  4. Abstract 97132026-09-02 · 14:15 CT · S100A
    Long-term follow-up of Keytruda 2L for metastatic melanoma: KEYNOTE-58
    M. Krop, G. Curigliano, L. Paz-Ares · Royal Marsden Hospital
    Education SessionMelanoma📄🖼️
  5. Abstract 103092026-09-03 · 21:15 CT · E450
    Keytruda plus chemotherapy in previously untreated metastatic melanoma: updated analysis from KEYNOTE-467
    H. Rugo, S. Modi, F. Andre · UCSF Helen Diller Family Comprehensive Cancer Center
    Education SessionMelanoma📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.